Understanding the Galaxy Medicare IPO GMP: Key Highlights

Galaxy Medicare Limited, incorporated in 1992, is a trusted name in medical consumables, producing surgical dressings, plaster of Paris bandages, and adhesive tapes under brands like POP BAND, G CAST, and CARETAPE. Operating from Bhubaneswar, Odisha, with 190 employees as of March 2025, it supplies to government health departments, corporate hospitals, and international markets like Bangladesh and Nepal

IPO Structure and Timeline

This book-built IPO balances fresh capital and promoter exits, with key details as follows:

• Total Issue Size: ₹22.31 crores, including 3.308 million fresh shares (₹17.86 crores) and 0.824 million offer-for-sale shares (₹4.45 crores).

• Price Band: ₹51 to ₹54 per share (face value ₹10).

• Lot Size: 2,000 shares per lot.

• Retail Minimum Investment: ₹2,16,000 for 4,000 shares (2 lots at upper band).

• HNI Minimum: ₹3,24,000 for 6,000 shares (3 lots).

• Subscription Period: September 10 to 12, 2025.

• Allotment Date: Expected September 15, 2025.

• Listing Date: Tentative September 17, 2025, on NSE SME.

Funds from the fresh issue will finance machinery upgrades (₹4.89 crores), working capital (₹8.94 crores), and general corporate purposes, strengthening its manufacturing edge.<grok:render type="render_inline_citation">6 The company’s ISO 9001:2015 and ISO 13485:2016 certifications ensure high-quality standards, boosting investor confidence.

Share Allocation Breakdown

• Retail Investors: 35% of the issue, encouraging broad participation.

• Non-Institutional Investors (NII): 15%.

• Qualified Institutional Buyers (QIB): 50%, including anchor investors.

• Market Maker: 208,000 shares (₹1.12 crores) for liquidity.

This structure supports balanced demand, potentially influencing the Galaxy Medicare IPO GMP upward with strong subscriptions.

Galaxy Medicare IPO GMP: Tracking Trends and Expectations

The Galaxy Medicare IPO GMP stands at ₹2, reflecting modest but positive grey market activity. Updated on September 10, 2025, this premium suggests a listing price of ₹56 against the ₹54 cap, yielding a 3.70% gain. Based on three grey market sessions, the trend is upward, with expectations of a solid listing.

Current GMP Snapshot

• Latest GMP: ₹2 (last updated September 10, 2025, 12:37 PM).

• Estimated Listing Price: ₹56 (upper band + GMP).

• Expected Gain: 3.70% per share; for a retail lot (4,000 shares), around ₹8,000 pre-expenses.

• Retail Sauda: ₹3,000, indicating grey market deal activity.

• GMP Range: Low of ₹0, high of ₹2, showing gradual momentum.<grok:render type="render_inline_citation">0

The Galaxy Medicare IPO GMP benefits from healthcare sector tailwinds, with rising demand for medical supplies in India and exports (₹8.47 crores in FY24).

Factors Driving Galaxy Medicare IPO GMP

Key influences on the Galaxy Medicare IPO GMP include:

• Healthcare Demand: Growing hospital networks and government health spending.

• Subscription Hype: Early retail interest could push GMP higher by close.<grok:render type="render_inline_citation">5

• Peer Performance: Recent healthcare SME IPOs like Anondita Medicare listed at 44% premiums, setting a benchmark.<grok:render type="render_inline_citation">19

• Export Growth: Stable international markets enhance revenue prospects.

Analysts suggest a potential 5-8% listing gain if subscriptions exceed 5x, though GMP isn’t definitive. Monitor registrar sites for updates.

Listing Price Outlook

At ₹56, a retail lot could yield ₹8,000, but actual performance depends on allotment and market sentiment. Strong QIB bids could elevate the Galaxy Medicare IPO GMP further.

Live Subscription Status: Day 1 Insights for Galaxy Medicare IPO

As of September 10, 2025 (Day 1), subscription data is emerging, with retail typically leading SME IPOs. While exact figures are pending, early trends suggest steady interest.

• Retail Category: Expected to drive oversubscription, fueled by healthcare appeal.

• NII Category: Moderate uptake, with HNIs assessing fundamentals.

• QIB Category: Anchor investors committed; broader QIB bids to pick up.

Check live status via Cameo Corporate Services Ltd. or NSE SME portal. High retail subscription could bolster the Galaxy Medicare IPO GMP.

How to Apply for Galaxy Medicare IPO: Step-by-Step Guide

Applying for the Galaxy Medicare IPO is seamless via ASBA/UPI. Minimum retail investment: ₹2,16,000 for 4,000 shares.

1. Access Demat Account: Log into brokers like Zerodha or Angel One.

2. Navigate IPO Section: Select Galaxy Medicare IPO from active issues.

3. Enter Bid Details: Choose lots (e.g., 2 for ₹2,16,000 at ₹54), set cut-off price.

4. Block Funds: Confirm UPI mandate by 5 PM, September 12.

5. Track Status: Use application number or PAN on September 15 for allotment.

HNIs bid for ≥3 lots (6,000 shares). Consult financial advisors to align with risk goals.

Application Best Practices

• Bid early to avoid technical issues.

• Verify KYC and UPI linkage.

• Balance IPO investments with portfolio diversification.

Financial Performance: Galaxy Medicare’s Growth Potential

Galaxy Medicare’s financials reflect resilience in the healthcare sector:

• Revenue Growth: ₹40.27 crores in FY25, up 9% from ₹36.94 crores in FY24.

• Profit After Tax: ₹3.37 crores in FY25, down 9% from ₹3.71 crores, due to cost pressures.

• Export Revenue: ₹8.47 crores in FY24, growing from ₹7.27 crores in FY23

• Debt-to-Equity: 0.52, indicating moderate leverage

• With 27 registered trademarks and a multi-channel model (OEM, tenders, exports), Galaxy Medicare is well-positioned. Audited financials confirm operational stability.

Strengths and Risks

Strengths:

• Strong domestic and export presence.

• Certified quality standards (ISO, CE).

• Diverse product portfolio for hospitals.

Risks:

• Regulatory compliance costs.

• Raw material price volatility.

• Competition from larger manufacturers.

Investors should weigh these against the modest Galaxy Medicare IPO GMP.

Conclusion: Is Galaxy Medicare IPO a Smart Bet?

The Galaxy Medicare IPO GMP of ₹2 hints at a 3.70% listing gain, backed by healthcare sector momentum. With subscriptions open until September 12 and listing on September 17, 2025, this SME IPO offers entry into a stable industry. As IPO analysts with deep market insights, we recommend tracking subscription trends and Galaxy Medicare IPO GMP daily while focusing on long-term fundamentals. Consult SEBI-registered experts for tailored advice.

Frequently Asked Questions (FAQs) About Galaxy Medicare IPO GMP

What is the current Galaxy Medicare IPO GMP?

As of September 10, 2025, the Galaxy Medicare IPO GMP is ₹2, with an estimated listing price of ₹56 (3.70% gain).

When does the Galaxy Medicare IPO subscription close?

The IPO closes on September 12, 2025, with allotment on September 15, 2025.

What is the minimum investment for retail investors in Galaxy Medicare IPO?

₹2,16,000 for 4,000 shares (2 lots at ₹54).

Why is the Galaxy Medicare IPO GMP low at ₹2?

Modest GMP reflects cautious sentiment in early sessions, but healthcare demand may push it higher.

What are the expected returns from Galaxy Medicare IPO?

Based on GMP, a 3.70% gain per share, potentially ₹8,000 for a retail lot, subject to market dynamics.

Where will Galaxy Medicare IPO list?

On NSE SME, tentatively on September 17, 2025.